Cohance Lifesciences Unveils Profile of Chairman Umang Vohra, Highlighting Three Decades of Industry Leadership
Cohance Lifesciences Limited, formerly Suven Pharmaceuticals Limited, has provided details regarding its leadership team, highlighting the extensive experience of its Chairman and Group CEO, Mr. Umang Vohra.Mr. Vohra brings over 30 years of distinguished experience in leading top Indian companies toward sustained growth. His professional journey began with foundational exposure to financial strategy and business planning at PepsiCo India, a global consumer enterprise.
His subsequent tenure included a notable period of over 14 years at Dr. Reddy's Laboratories. During his time there, Mr. Vohra served on the management team as CFO and head North America generics, where he was responsible for executing strategic growth decisions and expansion initiatives.
Most recently, Mr. Vohra joined Cipla Limited, serving as the Managing Director and Global CEO. He spent a decade at Cipla, where he was instrumental in the company’s global expansion, leading key launches, and spearheading national and international initiatives, guiding the organization through a period of transformative growth.
Academically, Mr. Umang Vohra holds a bachelor's degree in Engineering (Computer Science) from M.S. Ramaiah Institute of Technology, followed by a Master of Business Administration from T.A. Pai Management Institute.
COHANCE Stock Price Movement
Shares of Cohance Lifesciences Limited are edging higher to ₹432.1 as of 2:46 PM, rallying 19.99% for the day. The stock is showing strong buying interest, with trading volume reaching 13.91 million shares and sustaining upward momentum in the live market.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.